Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials. - Seshadri C; Flynn JL; Maiello P; Schnappinger D; Wilkinson RJ; Gordon SB; Mwandumba HC; Jambo KC; Hoft DF; Rubin EJ; Jamrozik E; Fortune SM; et al. (The Lancet. Microbe, 2026)